Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page to provide clearer disease context and improve discoverability.
    Difference
    0.2%
    Check dated 2025-12-17T10:18:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    13 days ago
    Change Detected
    Summary
    The page no longer lists the condition 'Multiple Myeloma' and the related topics 'MedlinePlus Genetics'.
    Difference
    0.2%
    Check dated 2025-12-09T00:27:41.000Z thumbnail image
  4. Check
    20 days ago
    Change Detected
    Summary
    Added related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' to the page to provide quick access to disease context and genetics resources. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-01T19:44:58.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Administrative revisions were made, updating from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:55:33.000Z thumbnail image
  6. Check
    34 days ago
    Change Detected
    Summary
    Removed the government funding notice banner and related topic links (Multiple Myeloma and MedlinePlus Genetics) from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T15:04:53.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The new screenshots show only visual changes to the Study Details page, including layout and formatting adjustments, with no modification to core study information such as title, inclusion/exclusion criteria, or outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T01:32:54.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.